The main driver of growth in the Multiple Sclerosis (MS) market is the introduction of novel DMT products over the forecast period. Drugs targeting clinical unmet needs; such as improved efficacy, more convenient administration, or progressive MS approval; will increase treatment rates and drive market growth. The biggest barrier for growth in the MS market will be competition from generic/biosimilar products for key branded therapies. In particular, the launch of generic small-molecules will hamper future growth of the MS market. Considerable opportunity remains for products that meet the unmet needs in the MS market. A drug that prevents disease progression and the accumulation of disability would be viewed favourably. Additionally, targeting progressive MS will be an ongoing opportunity.
GlobalData’s PharmaPoint: Multiple Sclerosis – Global Drug Forecast and Market Analysis to 2024 report provides analysis of the multiple sclerosis treatment space across the ten major markets of the US, France, Germany, Italy, Spain, the UK, Japan, Canada, China and India. It includes annualized market revenue, annual cost of therapy and treatment usage pattern data from 2014 and forecast for ten years to 2024.
The report includes:
- Overview of MS, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines
- Annualised MS market revenue, annual cost of therapy and treatment usage pattern data from 2014 and forecast for ten years to 2024
- Key topics covered include market characterization, unmet needs, R&D and clinical trials assessment, late stage clinical trial analysis and implications for the MS therapeutics market
- Analysis of the current and future market competition in the global MS therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
The MS market has experienced a paradigm shift with the launch of first-line oral DMTs and efficacious escalation therapies. Are you aware of the current clinical and environmental unmet needs? Will there be opportunities in this market for drug developers throughout the forecast period? Find out more!
The genetic testing market is growing at a high pace creating new life for the industry. The main factors propelling the BRIC countries are aging population, increase in genetic disorder incidences and rising awareness. The BRIC genetic testing market grew at a CAGR of 14.1% during 2007-2014. The market is forecast to reach $247.3 million in 2021 with a CAGR of 15.4% from 2014-2021.
GlobalData’s BRIC Genetic Testing Market Outlook to 2021 report is a comprehensive report, covering key market data on the BRIC Genetic Testing market.
The report covers:
- The three main market segments – Inborn Gene or Chromosome Alterations, Acquired Gene or Chromosome Alterations and Other Genetic Tests
- Annualised market revenues (USD) data for each of the market segments from 2007 to 2014 and forecast to 2021
- Global corporate-level profiles of key companies operating within the BRIC Genetic Testing Market
What’s the next big thing in the BRIC genetic testing market.. Find out now!
Petróleos Mexicanos (Pemex) has had a monopoly over the Mexican upstream oil and gas industry since 1938, but the government is now opening up the sector to outside investment in an effort to combat production declines. While the only outside investment in the sector was previously through limited service contracts granted by Pemex, the government will now be able to sign royalty and tax licenses, PSCs, profit-sharing contracts and service contracts with investors.
GlobalData’s Mexico Upstream Fiscal and Regulatory report presents the essential information relating to the terms which govern investment into Mexico’s upstream oil and gas sector. The report sets out in detail the new contractual frameworks introduced under the country’s energy reforms, clearly defining the factors affecting profitability and quantifying the state’s take from hydrocarbon production.
This report includes:
- An overview of fiscal terms governing upstream oil and gas operations in Mexico
- Details on the legal framework and governing bodies administering the industry
- Levels of upfront payments and taxation applicable to oil and gas production
- Details of the licensing process in ‘Round 1’
- Explanation of production sharing mechanisms in production sharing agreements
Do you have information on the special fiscal regime applicable to Petróleos Mexicanos (PEMEX)? Find out now!
Chinese Ammonia plant capacity has increased at a CAGR of 3.5% during 2005-15 and is expected to increase at a rate of 2.4% from to 2019, mainly dominated by public companies. such as China National Petroleum Corporation, China Petroleum & Chemical Corporation, Shanxi Jincheng Anthracite Mining Group Co., Ltd., and Sichuan Lutianhua Company Limited. Together, these companies accounted for 13.9% of the Ammonia capacity in China.
GlobalData’s Ammonia Industry Outlook in China to 2019 – Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants report covers China’s historical and forecast market size, demand and production forecasts, end-use demand details, price trends, trade balance data, and company shares of the country’s leading Ammonia producers.
This report provides:
- Comprehensive information of major planned & active ammonia projects & plants in China
- Capacity forecasts to 2019 with operator and equity details
- Ammonia industry market dynamics and supply scenario in China from 2005 to 2019
- Company capacity shares for key ammonia producers in China
Get a detailed company overview, business description, information on current and upcoming Ammonia plants for China Petroleum & Chemical Corporation, Shanxi Jincheng Anthracite Mining Group Co., Ltd., and China National Petroleum Corporation.
China will retain its world’s largest market share position for annual solar PV installations, adding around 17.6 GW this year. The US will far behind with 8.2 GW of additions, while India will witness strong demand in its solar PV market thanks to growing policy and political support. However, with Germany implementing initial measures to move away from expensive renewable energy subsidies and towards a reverse auction system by 2017 – will see reduction in installations. Similarly, Japan’s lucrative solar PV policies, which have been attracting strong investments in the recent years, have witnessed cuts that translate into a reduction in installed capacity additions, compared to the preceding record-breaking figure of 10 GW.
GlobalData’s Mid-Year Solar Power Market Update report provides analysis of the expected trends in the solar Photovoltaic (PV) market, including the demand-supply scenario in global solar sector, as well as commentaries on the major solar PV countries like Germany, Italy, India, China, Japan and the US.
This report includes:
- An analysis on expected trends in the solar market
- The demand-supply scenario in global solar market
- Key commentaries on the major solar PV markets
- Reduced solar photovoltaic additions in Germany and Japan will not dampen global growth. Find out how?
We are pleased to announce that QYResearch reports are now available on www.globalmarketanalyst.com
Established in 2007, the company focuses on custom research, management consulting, IPO consulting, industry chain research, database and seminar services.
QYResearch has always pursued product quality, adhere to the quality is the soul of business. Through the company’s years of effort and a lot of customer support, QYResearch consulting group creative design method of many high-quality markets investigation and research team with rich experience. Today, QYResearch brand has become the consulting industry with quality assurance consulting brand. The company has 4000 global well-known customers, covering energy automobile pharmaceutical chemical agriculture more than 30 industries, services from the data analysis and recommendations-Consulting landing one-stop solution, and research regions cover China,US,EU,Asia,Middle East and Africa,South America,Australia,etc
Research and marketing centers are available in China(Beijing Shanghai Guangzhou), USA, Canada, Germany, UK, France and Hong Kong. Currently, QYResearch has become the first choice of trusted consulting brand in the global and Chinese business consulting services.
For more information, you can browse QYResearch reports Here
The process towards a new lease sale schedule from 2017–2022 has started. The comments’ period on the draft of the proposed program closed in March 2015 and is expected to be released for comments in 2016. The program includes plans to open the south-eastern Atlantic region to oil and gas exploration, ranging from Virginia to Georgia, but faces considerable political and environmental opposition. Significant changes to the fiscal terms for US OCS leases are not expected in the short-to-medium term. However, there may be a greater potential for progress towards corporate tax reform when a new president takes office in 2017.
GlobalData’s US OCS Upstream Fiscal and Regulatory Report – Next Steps on 2017-2022 Lease Sale Program Expected in 2016 presents essential information relating to the terms which govern investment into the US Outer Continental Shelf (OCS)’s upstream oil and gas sector. The report sets out in detail the contractual framework under which firms must operate in the industry, clearly defining factors affecting profitability and quantifying the state’s take from hydrocarbon production.
- Published: Oct 2015
- Single User Price: $1,000
- Pages: 16
For more information, you can go to US OCS Upstream Fiscal and Regulatory Report – Next Steps on 2017-2022 Lease Sale Program Expected in 2016